Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years (2021)
Source: Materials Science & Engineering C. Unidade: FCF
Subjects: QUIMIOTERAPIA, ANTINEOPLÁSICOS, NEOPLASIAS, FARMACOCINÉTICA
ABNT
D'ANGELO, Natália A; NORONHA, Mariana Akemi; CÂMARA, Mayra C. C; et al. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Materials Science & Engineering C, Amsterdam, 2021. Disponível em: < https://dx.doi.org/10.1016/j.msec.2021.112623 > DOI: 10.1016/j.msec.2021.112623.APA
D'Angelo, N. A., Noronha, M. A., Câmara, M. C. C., Kurnik, I. S., Feng, C., Araújo, V. H. S., et al. (2021). Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Materials Science & Engineering C. doi:10.1016/j.msec.2021.112623NLM
D'Angelo NA, Noronha MA, Câmara MCC, Kurnik IS, Feng C, Araújo VHS, Santos JHPM, Feitosa VA, Molino JVD, Rangel-Yagui C de O, Chorilli M, Ho EA, Lopes AM. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years [Internet]. Materials Science & Engineering C. 2021 ;Available from: https://dx.doi.org/10.1016/j.msec.2021.112623Vancouver
D'Angelo NA, Noronha MA, Câmara MCC, Kurnik IS, Feng C, Araújo VHS, Santos JHPM, Feitosa VA, Molino JVD, Rangel-Yagui C de O, Chorilli M, Ho EA, Lopes AM. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years [Internet]. Materials Science & Engineering C. 2021 ;Available from: https://dx.doi.org/10.1016/j.msec.2021.112623